Table 1. Input parameters of FluTe and the SEIR model.

	SEIR	FluTe				Source
Latent period duration (LPD)	1.9 days	1.9 days‡				[6]
Total disease duration (TDD)	6 days	6 days				[6]
Infectious period duration (IPD)	4.1 days	4.1 days				TDD−LPD
Transition rate
Exposed-to-Infectious(τu)	0.52632	–				(LPD)−1
Exposed-to-Recovered (γ)	0.1667	–				(TDD)−1
Infectious-to-Recovered (ξ)	0.2439	–				(IPD)−1
Likelihood
of showing the symptoms (ωu)†	0.67	0.67				[6]
		Transmission rate/probability (βu)*		Initial number of infections (b)
		SEIR	FluTe	SEIR	FluTe
Basic reproduction number (R0)	1.2	0.0044	0.2057	19.48	10	Calibration and [6]
	1.4	0.0053	0.2435	22.07	10
	1.6	0.0063	0.2812	7.88	10
	1.8	0.0071	0.3190	5.01	10
	2.0	0.0077	0.3567	5.01	10
	2.2	0.0083	0.3944	5.01	10
	2.4	0.0089	0.4322	5.01	10
Age group specific disease parameters
	0–4	5–18	19–29	30–64	65+
Population size	36,722	124,787	71,601	265,047	65,303	[6]
Death rate (unvaccinated-χu)	0.0049	0.002	0.0056	0.0038	0.001	[13]
Death rate (vaccinated-χv)	0.0012	0.0005	0.0017	0.0011	0.0004	[13]
Vaccine efficacy in
becoming infected	40%	40%	40%	40%	24%	[6]
transmitting the disease	40%	40%	40%	40%	24%	[6]
showing the symptoms	67%	67%	67%	67%	40%	[6]
Performance related parameters
	0–4	5–18	19–29	30–64	65+
Infection cost (unvaccinated)($)	275.3	275.3	328.98	328.98	492.56	[13]
Infection cost (vaccinated)($)	231.58	231.58	264.71	264.71	404.54	[13]
Terminal care cost($)	3,435	3,435	7,605	7,605	8,309	[13]
Vaccination cost ($)	37.26	37.26	37.26	37.26	37.26	[13]
YLL (years)	79.42	70.71	57.92	36.45	13.37	[39, 40]

^‡: Mean of a discrete distribution of 1, 2, or 3 days with probabilities 0.3, 0.5, and 0.2.

^†: These numbers are for the unvaccinated individuals. For the vaccinated individuals, they should be multiplied by (1- vaccine efficacy in showing the symptoms).

*: These numbers are for the unvaccinated individuals. For the vaccinated individuals, they should be multiplied by (1- vaccine efficacy in transmitting the disease).